Search

for
Search:

GlossaryBRAF inhibitors

drugs that block mutated BRAF protein to treat cancer

BRAF inhibitors are a class of drugs designed to block the activity of the BRAF protein, which is involved in sending signals inside cells and can contribute to cancer growth when mutated. These inhibitors are particularly used in treating certain types of melanoma and other cancers with specific BRAF mutations, helping to slow down or stop the progression of the disease.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 348 results

research The Influence of Flightless I: Regeneration Versus Wound Healing

1 citations , March 2011 in “Journal of Investigative Dermatology”

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

research Adverse Hair Reactions to New Targeted Therapies for Cancer

1 citations , March 2019 in “Actas Dermo-Sifiliográficas”

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: The Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma

research The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: The Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma

6 citations , April 2013 in “Current Dermatology Reports”

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

research The Spectrum of Cutaneous Adverse Events During Encorafenib and Binimetinib Treatment in B-Rapidly Accelerated Fibrosarcoma-Mutated Advanced Melanoma

21 citations , November 2018 in “Journal of the European Academy of Dermatology and Venereology”

The combination of encorafenib and binimetinib caused few skin issues.

research Cutaneous Adverse Effects of BRAF Inhibitors in Metastatic Malignant Melanoma: A Prospective Study in 20 Patients

31 citations , March 2014 in “Journal of the European Academy of Dermatology and Venereology”

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

View more "braf inhibitors" in research →

Community Join

1 / 1 results

community Huge Group Buy is Now Live with New and Existing Treatments

in Product 146 upvotes 2 years ago

A group buy for hair loss treatments including Harmine 19a, TM5614, Abiraterone Acetate, and others. A compound, BMS-202, that can potentially reverse gray hair is also mentioned.